During the past decade, Saitama Children's Medical Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saitama Children's Medical Center" #1 sponsor was "BioMarin Pharmaceutical" with 5 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored, "Shire" with 2 trials sponsored and "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Children's Medical Center" #1 collaborator was "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Saitama Children's Medical Center" are "Achondroplasia" (5 trials), "Nervous System Diseases" (2 trials), "Sarcoma" (2 trials), "Alport Syndrome" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Saitama Children's Medical Center" in a lesser frequency.

Most popular intervention types in "Saitama Children's Medical Center" are "Drug" (17 trials), "Biological" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BMN 111" (3 trials), "Matching Placebo" (2 trials), "SHP615" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saitama Children's Medical Center" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Saitama Children's Medical Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Saitama Children's Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saitama Children's Medical Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".